Zean Li

Guangdong Provincial Key Laboratory Of Malignant Tumor Epigenetics And Gene Regulation
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

WFDC21P is essential for G3BP1-mediated RIG-I activation and antitumor immunity in triple-negative breast cancer.

WFDC21P is essential for G3BP1-mediated RIG-I activation and antitumor immunity in triple-negative breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 31, 2026

Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics.

Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: October 27, 2025

PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer.

PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer.

Journal: Cell death & disease

Published: July 24, 2025

Induction of ferroptosis in prostate cancer by CCDC719-13 via TRIM21-mediated ubiquitination of SLC7A11.

Induction of ferroptosis in prostate cancer by CCDC719-13 via TRIM21-mediated ubiquitination of SLC7A11.

Journal: Cell death and differentiation

Published: May 25, 2025

Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression.

Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 15, 2025

An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer.

An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer.

Journal: Journal of translational medicine

Published: October 12, 2024

Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer.

Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer.

Journal: International journal of biological sciences

Published: July 16, 2024

SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion.

SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion.

Journal: Journal of translational medicine

Published: December 01, 2022

SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway.

SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway.

Journal: Cancer medicine

Published: September 19, 2022

Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer.

Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer.

Journal: Cancer biology & medicine

Published: September 30, 2021

Suprapubic Transvesical Repair of Vesicovaginal Fistula Using a Homemade Laparoscopic Single-Port Device: Experience of 42 Patients.

Suprapubic Transvesical Repair of Vesicovaginal Fistula Using a Homemade Laparoscopic Single-Port Device: Experience of 42 Patients.

Journal: Frontiers in surgery

Published: July 20, 2021

The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signaling.

The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signaling.

Journal: Clinical and translational medicine

Published: July 16, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026